Ali Esfahani

1.3k total citations
73 papers, 974 citations indexed

About

Ali Esfahani is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Ali Esfahani has authored 73 papers receiving a total of 974 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 11 papers in Molecular Biology and 11 papers in Hematology. Recurrent topics in Ali Esfahani's work include Vitamin D Research Studies (5 papers), Gastric Cancer Management and Outcomes (5 papers) and Acute Myeloid Leukemia Research (5 papers). Ali Esfahani is often cited by papers focused on Vitamin D Research Studies (5 papers), Gastric Cancer Management and Outcomes (5 papers) and Acute Myeloid Leukemia Research (5 papers). Ali Esfahani collaborates with scholars based in Iran, Australia and United States. Ali Esfahani's co-authors include Zohreh Ghoreishi, Mohammad Asghari Jafarabadi, Roya Dolatkhah, Seyed Ali Keshavarz, Alireza Farsad-Naeimi, Mohammad Alizadeh, Alireza Ostadrahimi, Hormoz Ayromlou, Iraj Asvadi Kermani and Zohreh Sanaat and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Annals of Oncology.

In The Last Decade

Ali Esfahani

70 papers receiving 936 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ali Esfahani Iran 18 262 184 119 94 91 73 974
Kunihiko Ishitani Japan 16 444 1.7× 306 1.7× 95 0.8× 125 1.3× 102 1.1× 48 1.1k
Fezan Mutlu Türkiye 18 92 0.4× 136 0.7× 112 0.9× 114 1.2× 80 0.9× 91 1.0k
Ming‐Chih Chou Taiwan 21 159 0.6× 292 1.6× 209 1.8× 32 0.3× 157 1.7× 64 1.3k
Ling Jiang China 19 152 0.6× 263 1.4× 102 0.9× 107 1.1× 104 1.1× 93 1.0k
Ebrahim Shakiba Iran 21 121 0.5× 153 0.8× 152 1.3× 52 0.6× 42 0.5× 98 1.2k
Anita Margulies Switzerland 12 661 2.5× 126 0.7× 86 0.7× 48 0.5× 190 2.1× 15 1.8k
Jingwei Chi China 18 170 0.6× 399 2.2× 124 1.0× 25 0.3× 60 0.7× 52 1.4k
Jamila Alessandra Perini Brazil 19 138 0.5× 232 1.3× 45 0.4× 41 0.4× 67 0.7× 72 1.5k
Yin Huang China 17 213 0.8× 212 1.2× 119 1.0× 32 0.3× 147 1.6× 58 1.1k
Kinjal Shah Sweden 14 352 1.3× 462 2.5× 139 1.2× 59 0.6× 219 2.4× 33 1.6k

Countries citing papers authored by Ali Esfahani

Since Specialization
Citations

This map shows the geographic impact of Ali Esfahani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Esfahani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Esfahani more than expected).

Fields of papers citing papers by Ali Esfahani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Esfahani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Esfahani. The network helps show where Ali Esfahani may publish in the future.

Co-authorship network of co-authors of Ali Esfahani

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Esfahani. A scholar is included among the top collaborators of Ali Esfahani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Esfahani. Ali Esfahani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Safaralizadeh, Reza, Babak Nejati, Ali Esfahani, et al.. (2025). miRNAs as emerging predictors of tamoxifen resistance in breast cancer. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(8). 9499–9515.
2.
Esfahani, Ali, et al.. (2024). Serum vitamin D levels and their correlation with pro-inflammatory prostaglandins in Acute myeloid leukemia: a cross-sectional analysis. Scientific Reports. 14(1). 32069–32069. 1 indexed citations
3.
4.
Montazersaheb, Soheila, et al.. (2017). Molecular analysis of more than 140 gene fusion variants and aberrant activation of EVI1 and TLX1 in hematological malignancies. Annals of Hematology. 96(10). 1605–1623. 2 indexed citations
5.
Esfahani, Ali, Mohammad Hossein Somi, Hormoz Ayromlou, et al.. (2016). The effect of n-3 polyunsaturated fatty acids on incidence and severity of oxaliplatin induced peripheral neuropathy: a randomized controlled trial. Biomarker Research. 4(1). 13–13. 18 indexed citations
6.
Somi, Mohammad Hossein, et al.. (2014). The effects of neoadjuvant chemotherapy on resectability of locally-advanced gastric adenocarcinoma: A clinical trial. International Journal of Surgery. 12(10). 1061–1069. 22 indexed citations
7.
Kermani, Iraj Asvadi, et al.. (2014). Taurine attenuates chemotherapy-induced nausea and vomiting in acute lymphoblastic leukemia. Amino Acids. 47(1). 101–109. 18 indexed citations
8.
9.
Esfahani, Ali, et al.. (2013). Nutritional assessment of patients with acute leukemia during induction chemotherapy: association with hospital outcomes. Leukemia & lymphoma. 55(8). 1743–1750. 30 indexed citations
10.
Sayyah-Melli, Manizheh, et al.. (2013). Comparison of Platinum-based Neoadjuvant Chemotherapy and Primary Debulking Surgery in Patients with Advanced Ovarian Cancer. The Journal of Obstetrics and Gynecology of India. 63(6). 405–409. 6 indexed citations
11.
Izadi, Morteza, Seyed Hassan Saadat, Bahram Pishgoo, et al.. (2013). Chlamydia pneumoniae in the atherosclerotic plaques of coronary artery disease patients.. PubMed. 51(12). 864–70. 5 indexed citations
12.
Karami, Hadi, Behzad Baradaran, Ali Esfahani, et al.. (2013). siRNA-mediated Silencing of Survivin Inhibits Proliferation and Enhances Etoposide Chemosensitivity in Acute Myeloid Leukemia Cells. Asian Pacific Journal of Cancer Prevention. 14(12). 7719–7724. 39 indexed citations
13.
Dolatkhah, Roya, Ali Esfahani, Iraj Asvadi Kermani, et al.. (2013). Delayed hemolytic transfusion reaction with multiple alloantibody (Anti S, N, K) and a monospecific autoanti-JK b in intermediate β-thalassemia patient in Tabriz. Asian Journal of Transfusion Science. 7(2). 149–149. 7 indexed citations
14.
Dolatkhah, Roya, et al.. (2013). Successful Management of Total Knee Replacement in a High Responder Hemophilia Patient With a History of Inhibitor. Iranian Red Crescent Medical Journal. 15(1). 18–20. 2 indexed citations
15.
Ghoreishi, Zohreh, Ali Esfahani, Abolghasem Djazayeri, et al.. (2012). Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: A randomized double-blind placebo controlled trial. BMC Cancer. 12(1). 355–355. 115 indexed citations
16.
Izadi, Morteza, Seyed Hassan Saadat, Hossein Dabiri, et al.. (2012). Cytomegalovirus Localization in Atherosclerotic Plaques is Associated with Acute Coronary Syndromes: Report of 105 Patients. Methodist DeBakey Cardiovascular Journal. 8(2). 42–42. 23 indexed citations
17.
Kermani, Iraj Asvadi, et al.. (2011). Association of serum level of 25 hydroxy-vitamin D with prognostic factors for breast cancer.. PubMed. 12(6). 1381–4. 16 indexed citations
18.
Esfahani, Ali, et al.. (2008). Association of drinking water and prevalence of intestinal parasites in military persons. Majallah-i ṭibb-i niẓāmī. 10(3). 159–166. 3 indexed citations
19.
Esfahani, Ali, et al.. (2007). Seroepidemiology of Hepatitis E Virus in Iranian Soldiers. Hepatitis Monthly. 7(3). 123–126. 21 indexed citations
20.
Ranjbar, Reza, et al.. (2007). Evaluation Education Effect of Face to Face and Pamphelet on Knowledge and Attitude About AIDS in Adult. Majallah-i ṭibb-i niẓāmī. 9(131). 57–65.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kunihiko Ishitani Breakdown of academic impact, for papers by Fezan Mutlu Breakdown of academic impact, for papers by Ming‐Chih Chou Breakdown of academic impact, for papers by Ling Jiang Breakdown of academic impact, for papers by Ebrahim Shakiba Breakdown of academic impact, for papers by Anita Margulies Breakdown of academic impact, for papers by Jingwei Chi Breakdown of academic impact, for papers by Jamila Alessandra Perini Breakdown of academic impact, for papers by Yin Huang Breakdown of academic impact, for papers by Kinjal Shah
Rankless by CCL
2026